Pfizer : PFE

All Pfizer Articles

1533 Articles

Paul Ausick | Sep 26, 2016 at 4:01 PM EDT

Goldman Sachs, JPMorgan Sink DJIA Monday

September 26, 2016: Markets opened lower again Monday and only the recently added real-estate sector traded higher on the day.…

Chris Lange | Sep 26, 2016 at 11:10 AM EDT

Pfizer Decides Against the Split

Pfizer shares traded down marginally Monday morning after the company announced that it will abandon its plan to split into…

Lee Jackson | Sep 20, 2016 at 9:50 AM EDT

5 Dividend Paying Stocks Deutsche Bank Likes If Trump Wins in November

While the polls have the race pretty tight, one thing is for sure: a victory by Donald Trump would favor…

Lee Jackson | Sep 14, 2016 at 8:25 AM EDT

Fed Won’t Raise Until December: Buy These 4 Dividend Blue Chips On Sale

The volatility in the markets have shaken some of the top dividend leaders and may be giving long-term investors a…

Chris Lange | Sep 13, 2016 at 10:25 AM EDT

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to…

Chris Lange | Sep 13, 2016 at 7:25 AM EDT

Major Pharma Continues to See Significant Drop in Short Interest

The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Lee Jackson | Aug 31, 2016 at 8:20 AM EDT

3 Biotech Stocks Could Be the Next Big Takeover Targets

In a new research report, Baird notes two biotech companies in its research coverage universe that may be considered speculative…

Chris Lange | Aug 25, 2016 at 8:45 AM EDT

Major Pharma Short Interest Faces Significant Drop

The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Paul Ausick | Aug 22, 2016 at 7:55 AM EDT

Pfizer Pays a Big Premium for Medivation

In one of the longest running bidding wars in recent times, Pfizer has finally reeled in cancer-drug maker Medivation.

Jon C. Ogg | Aug 18, 2016 at 12:50 PM EDT

How Much Medivation Can Really Fetch in a Buyout

Medivation has been among the top future biotech mergers for quite some time. The problem is that we still have…

Paul Ausick | Aug 17, 2016 at 4:01 PM EDT

3M, Chevron Pull Dow Higher Wednesday

August 17, 2016: Markets opened slightly lower Wednesday following a slide in European markets. Utility stocks were the leading sector…

Jon C. Ogg | Aug 15, 2016 at 1:05 PM EDT

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

Credit Suisse has run bullish and bearish scenarios for what the firm feels is a reasonable upside and downside for…

Jon C. Ogg | Aug 13, 2016 at 9:15 AM EDT

10 Merrill Lynch Equity Income Portfolio Picks for Safe High-Dividend Yields

In the latest Merrill Lynch RIC Report, which is effectively a culmination of the firm's top research ideas, views and…

Jon C. Ogg | Aug 11, 2016 at 4:33 PM EDT

5 DJIA Stocks That Really Missed Out on the All-Time High Rally Thursday

The Dow Jones Industrial Average hit yet another all-time high on Thursday, August 11, 2016. What is amazing is that…

Chris Lange | Aug 10, 2016 at 9:05 AM EDT

Major Pharma Short Interest Slides

The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

1 … 49 50 51 52 53 … 103

Pfizer : PFE

All Pfizer Articles

Goldman Sachs, JPMorgan Sink DJIA Monday

Pfizer Decides Against the Split

5 Dividend Paying Stocks Deutsche Bank Likes If Trump Wins in November

Fed Won’t Raise Until December: Buy These 4 Dividend Blue Chips On Sale

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Major Pharma Continues to See Significant Drop in Short Interest

3 Biotech Stocks Could Be the Next Big Takeover Targets

Major Pharma Short Interest Faces Significant Drop

Pfizer Pays a Big Premium for Medivation

How Much Medivation Can Really Fetch in a Buyout

3M, Chevron Pull Dow Higher Wednesday

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

10 Merrill Lynch Equity Income Portfolio Picks for Safe High-Dividend Yields

5 DJIA Stocks That Really Missed Out on the All-Time High Rally Thursday

Major Pharma Short Interest Slides

$22 Billion in Customer Deposits Did Not Stop This Chip CEO From Selling $37 Million

This Chinese Tech Giant Quietly Cut Its Buyback 80% to Fund AI

DIVO Was the Quality-Income Pick. Its International Twin Yields 5.6% and Beat It by 5 Points

Nobody Plans to Retire Alone in The Villages. Here's What It Costs When It Happens

Nobody Warned Her That Two Retirement Accounts Meant Two RMD Rules, a 25% Penalty

$22 Billion in Customer Deposits Did Not Stop This Chip CEO From Selling $37 Million

This Chinese Tech Giant Quietly Cut Its Buyback 80% to Fund AI

Pfizer : PFE

All Pfizer Articles

Goldman Sachs, JPMorgan Sink DJIA Monday

Pfizer Decides Against the Split

5 Dividend Paying Stocks Deutsche Bank Likes If Trump Wins in November

Fed Won’t Raise Until December: Buy These 4 Dividend Blue Chips On Sale

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Major Pharma Continues to See Significant Drop in Short Interest

3 Biotech Stocks Could Be the Next Big Takeover Targets

Major Pharma Short Interest Faces Significant Drop

Pfizer Pays a Big Premium for Medivation

How Much Medivation Can Really Fetch in a Buyout

3M, Chevron Pull Dow Higher Wednesday

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

10 Merrill Lynch Equity Income Portfolio Picks for Safe High-Dividend Yields

5 DJIA Stocks That Really Missed Out on the All-Time High Rally Thursday

Major Pharma Short Interest Slides

$22 Billion in Customer Deposits Did Not Stop This Chip CEO From Selling $37 Million

This Chinese Tech Giant Quietly Cut Its Buyback 80% to Fund AI

DIVO Was the Quality-Income Pick. Its International Twin Yields 5.6% and Beat It by 5 Points

Featured Reads

Nobody Plans to Retire Alone in The Villages. Here's What It Costs When It Happens

Nobody Warned Her That Two Retirement Accounts Meant Two RMD Rules, a 25% Penalty